Pharma & Biotech Patent Litigation
Jane Lambert For the second year running, I have been invited to address C5's annual conference on Pharma & Biotech Litigation . That conference will take place at the Radisson Blu Hotel in Amsterdam between 26 and 27 Feb 2019. Last year I discussed the Supreme Court's decision in Eli Lilly v Actavis UK Ltd and others [2017] Bus LR 1731, [2017] UKSC 48, [2017] RPC 21 with partners from the Dutch and German offices of DLA. This year I shall be sharing a platform with Anna P. López Lozano who is head of IP at Esteve in Barcelona on the topic of Maximizing IP Regulatory Rights. I shall be talking about supplementary protection certificates, a topic that I have recently addressed in the context of Brexit in Patents of there is no Deal 3 Oct 2018 NIPC Brexit. Brexit is one of the key themes of the 2019 conference and there be a pre-conference workshop on the topic on 25 Feb 2019 entitled READY, STEADY, BREXIT...